We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
-13.35%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$13.1B
AUM Growth
-$2.19B
Cap. Flow
-$122M
Cap. Flow %
-0.93%
Top 10 Hldgs %
45.5%
Holding
27
New
1
Increased
1
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$592M
2
MCO icon
Moody's
MCO
+$537M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$261M
2
ARW icon
Arrow Electronics
ARW
+$197M
3
LHX icon
L3Harris
LHX
+$130M
4
BDX icon
Becton Dickinson
BDX
+$123M
5
GWW icon
W.W. Grainger
GWW
+$119M

Sector Composition

Rank Sector Weight
1 Healthcare 27.65%
2 Financials 25.41%
3 Technology 19.65%
4 Industrials 8.85%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
1
IQVIA
IQV
$40.7B
$624M 4.77%
2,875,975
-264,638
-8% -$57.5M
SYY icon
2
Sysco
SYY
$40.8B
$612M 4.68%
7,225,944
-666,839
-8% -$55.9M
UNH icon
3
UnitedHealth
UNH
$382B
$612M 4.68%
1,191,159
-518,826
-30% -$261M
MRSH
4
Marsh
MRSH
$94.3B
$608M 4.65%
3,918,022
-423,861
-10% -$67.9M
AON icon
5
Aon
AON
$80.6B
$603M 4.61%
2,235,491
-256,928
-10% -$73.8M
HSIC icon
6
Henry Schein
HSIC
$9.78B
$589M 4.5%
7,669,571
-879,502
-10% -$73.7M
BDX icon
7
Becton Dickinson
BDX
$46.4B
$585M 4.47%
2,372,341
-486,383
-17% -$123M
GWW icon
8
W.W. Grainger
GWW
$64.2B
$582M 4.45%
1,281,802
-244,240
-16% -$119M
LHX icon
9
L3Harris
LHX
$55.4B
$576M 4.4%
2,381,075
-538,127
-18% -$130M
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.12T
$561M 4.29%
5,148,680
-151,000
-3% -$17.8M
MSFT icon
11
Microsoft
MSFT
$2.9T
$560M 4.28%
+2,180,497
New +$592M
ORCL icon
12
Oracle
ORCL
$339B
$555M 4.24%
7,944,126
-15,300
-0.2% -$1.12M
CDW icon
13
CDW
CDW
$18.9B
$552M 4.22%
3,505,447
-5,300
-0.2% -$891K
BNY
14
Bank of New York Mellon
BNY
$103B
$541M 4.14%
12,971,804
-152,700
-1% -$6.8M
AXP icon
15
American Express
AXP
$224B
$531M 4.06%
3,832,917
-83,980
-2% -$13.9M
MCO icon
16
Moody's
MCO
$83.7B
$530M 4.05%
1,948,580
+1,796,385
+1,180% +$537M
STT icon
17
State Street
STT
$48.4B
$511M 3.91%
8,287,921
-2,200
-0% -$156K
HCA icon
18
HCA Healthcare
HCA
$90.6B
$510M 3.9%
3,033,039
-1,410
-0% -$303K
FISV
19
Fiserv Inc
FISV
$29.7B
$504M 3.85%
5,660,944
-4,800
-0.1% -$466K
TJX icon
20
TJX Companies
TJX
$179B
$499M 3.82%
8,935,569
-4,500
-0.1% -$272K
CHTR icon
21
Charter Communications
CHTR
$17.3B
$467M 3.57%
997,593
-660
-0.1% -$322K
MDT icon
22
Medtronic
MDT
$112B
$466M 3.56%
5,186,692
-2,200
-0% -$223K
FIS icon
23
Fidelity National Information Services
FIS
$24.2B
$400M 3.06%
4,364,306
-2,400
-0.1% -$238K
USFD icon
24
US Foods
USFD
$22.5B
$271M 2.07%
8,834,940
-26,700
-0.3% -$903K
ZBH icon
25
Zimmer Biomet
ZBH
$18.8B
$233M 1.78%
2,215,607
-840
-0% -$99.7K

Similar funds

Longview Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Longview Partners held 27 positions worth $13.1B, down 14% from $15.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Longview Partners's Q2 2022 filing shows 1 new, 1 increased, 23 reduced and 2 closed positions. Its largest new stake was Microsoft: 2,180,497 shares worth $560M. The largest sale was UnitedHealth, an estimated $261M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Financials and Technology.

  • Longview Partners's largest Q2 2022 buy was Microsoft: 2,180,497 shares worth $560M.
  • Longview Partners added most to Moody's in Q2 2022, an estimated $537M increase.
  • Longview Partners's biggest Q2 2022 reduction was UnitedHealth, cutting an estimated $261M.
  • Longview Partners fully exited Arrow Electronics in Q2 2022, selling an estimated $197M.
  • Longview Partners's ten largest holdings make up 45% of its $13.1B portfolio in Q2 2022.
  • Longview Partners opened 1 new position and closed 2 in Q2 2022.
  • Longview Partners's portfolio value fell 14% quarter-over-quarter to $13.1B.

Based on Longview Partners's 13F filing for Q2 2022, filed 12 Aug 2022.